BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6123325)

  • 21. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.
    Shin Y; Romstedt KJ; Doyle K; Harrold MW; Gerhardt MA; Miller DD; Patil PN; Feller DR
    Chirality; 1991; 3(2):112-7. PubMed ID: 1830752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
    Shin Y; Romstedt KJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin release by trimetoquinol in normal and asthmatic subjects.
    Kurosawa M; Nemoto T; Kobayashi S
    Ann Allergy; 1980 May; 44(5):317-22. PubMed ID: 6103681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiating effects of clofibrate on prostaglandin-dependent and -independent pathways of human platelet activation: evidence for involvement of cyclic AMP.
    Huzoor-Akbar ; Witiak DT; Newman HA; Fertel RH; Feller DR
    Biochem Pharmacol; 1982 Jun; 31(11):2125-8. PubMed ID: 6288050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and platelet antiaggregatory activity of trimetoquinol analogs as endoperoxide/thromboxane A2 antagonists.
    Harrold MW; Gerhardt MA; Romstedt K; Feller DR; Miller DD
    Drug Des Deliv; 1987 Feb; 1(3):193-207. PubMed ID: 3509333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet accumulation on fibrinogen-blockade of the prostaglandin and ADP pathways.
    Feuerstein IA; Dickson VM
    Trans Am Soc Artif Intern Organs; 1982; 28():437-43. PubMed ID: 7164277
    [No Abstract]   [Full Text] [Related]  

  • 27. Biochemical and pharmacological characterization of high-affinity trimetoquinol analogs on guinea pig and human beta adrenergic receptor subtypes: evidence for partial agonism.
    Fraundorfer PF; Fertel RH; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1994 Aug; 270(2):665-74. PubMed ID: 7915318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.
    Romstedt KJ; Shin Y; Shams G; Doyle K; Tantishaiyakul V; Clark MT; Adejare A; Hamada A; Miller DD; Feller DR
    Biochem Pharmacol; 1993 Dec; 46(11):2051-9. PubMed ID: 8267653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of antiplatelet and antithrombotic drugs.
    Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
    Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
    [No Abstract]   [Full Text] [Related]  

  • 30. Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism.
    Hashizume T; Sato T; Fujii T
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):243-7. PubMed ID: 1540140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
    Teng CM; Chen YH; Ouyang C
    Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimethoquinol is a potent prostaglandin endoperoxide antagonist [proceedings].
    MacIntyre DE; Willis AL
    Br J Pharmacol; 1978 Jun; 63(2):361P. PubMed ID: 667443
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimethoquinol selectively antagonises longitudinal muscle contractions of rat isolated gastric fundus to thromboxane B2 and epoxymethano analogues of PGH2 [proceedings].
    Bennett A; Sanger GJ
    Br J Pharmacol; 1979 Jul; 66(3):450P. PubMed ID: 526738
    [No Abstract]   [Full Text] [Related]  

  • 36. Trimethoquinol selectively antagonizes contractions of rat gastric fundus to TXB2 and epoxymethano analogs of PGH2.
    Sanger GJ; Bennett A
    Adv Prostaglandin Thromboxane Res; 1980; 8():1559-60. PubMed ID: 6103666
    [No Abstract]   [Full Text] [Related]  

  • 37. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
    J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical activities of trimetoquinol analogs at human beta(1)- and beta(3)-adrenergic receptors.
    Konkar AA; Nikulin VI; De Los Angeles J; Hong SS; Fertel RH; Miller DD; Feller DR
    Pharmacology; 2001 Jan; 62(1):45-55. PubMed ID: 11150922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
    Joseph S; Krishnamurthi S; Kakkar VV
    Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.
    Mazurov AV; Menshikov MYu ; Leytin VL; Tkachuk VA; Repin VS
    FEBS Lett; 1984 Jul; 172(2):167-71. PubMed ID: 6086387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.